Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Doxycycline 40mg modified-release capsules |
BNF code | 0501030Z0AAAAAA |
Virtual Therapeutic Moiety | Doxycycline |
Date identifier became valid | 17 Jan 2019 |
Previous product identifier | 423491006 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | capsule |
Unit dose unit of measure | capsule |
Virtual Product Ingredient | |
---|---|
Ingredient | Doxycycline monohydrate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 372478003 |
Strength value numerator | 40.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | capsulemodified-release.oral |
Dose Form | |
Formulation | Modified-release capsule |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Efracea 40mg modified-release capsules (Galderma (UK) Ltd) | |
Virtual Medicinal Product Packs | |
Doxycycline 40mg modified-release capsules 14 capsule | |
Doxycycline 40mg modified-release capsules 56 capsule |
dm+d data retrieved from TRUD: release NHSBSA_11.3.0_20241125000001, imported on 26th November 2024 at 03:54:16.